JiscMail Logo
Email discussion lists for the UK Education and Research communities

Help for ACB-CLIN-CHEM-GEN Archives


ACB-CLIN-CHEM-GEN Archives

ACB-CLIN-CHEM-GEN Archives


ACB-CLIN-CHEM-GEN@JISCMAIL.AC.UK


View:

Message:

[

First

|

Previous

|

Next

|

Last

]

By Topic:

[

First

|

Previous

|

Next

|

Last

]

By Author:

[

First

|

Previous

|

Next

|

Last

]

Font:

Proportional Font

LISTSERV Archives

LISTSERV Archives

ACB-CLIN-CHEM-GEN Home

ACB-CLIN-CHEM-GEN Home

ACB-CLIN-CHEM-GEN  2004

ACB-CLIN-CHEM-GEN 2004

Options

Subscribe or Unsubscribe

Subscribe or Unsubscribe

Log In

Log In

Get Password

Get Password

Subject:

Re: Assaulting patients with added tests

From:

Joseph WATINE <[log in to unmask]>

Reply-To:

Joseph WATINE <[log in to unmask]>

Date:

Wed, 21 Apr 2004 11:49:01 +0000

Content-Type:

multipart/mixed

Parts/Attachments:

Parts/Attachments

text/plain (115 lines) , message/rfc822 (115 lines)

In order to avoid being criticized for adding tests, which will often be 
paid by the patients (at least here in France), shouldn't we ask the 
patients if he/she agrees first?

Dr Joseph Watine, PH, AIHP, PharmD, AAHU, EurClinChem
Laboratoire de Biologie Polyvalente
Centre Hospitalier Général
12027 Rodez Cedex 9
France

>From: Mohammad Al-Jubouri <[log in to unmask]>
>Reply-To: Mohammad Al-Jubouri <[log in to unmask]>
>To: [log in to unmask]
>Subject: Re: Assaulting patients with added tests
>Date: Wed, 21 Apr 2004 10:44:46 +0100
>
>Thanks Elizabeth
>
>I don't have any problem with discussing added tests with the requesting 
>clinician (a time taxing process) if this is feasible. We have sometimes 
>real problems in communicating urgent results to the requesting clinician. 
>I mentioned this single anecdotal case for the flavour only, but I hope 
>that you would have realised that it wasn't the only case that changed my 
>practice. In my humble experience I did publish few cases and there are 
>many others published by colleagues:
>
>1. Xanthoderma: an unusual presentation of hypothyroidism.
>Al-Jubouri MA, Coombes EJ, Young RM, McLaughlin NP.
>J Clin Pathol. 1994 Sep;47(9):850-1.
>
>2.Myxoedema revealed by simvastatin induced myopathy.
>Al-Jubouri MA, Briston PG, Sinclair D, Chinn RH, Young RM.
>BMJ. 1994 Feb 26;308(6928):588.
>
>3.Hypertriglyceridaemia: a pointer to diabetes mellitus and alcoholism.
>Al-Jubouri MA, Young RM.
>Ann Clin Biochem. 1993 Mar;30 ( Pt 2):201-2.
>
>Computerisation is wonderful, but I did mention adding tests after 
>consideration of clinical details (which sometimes mean phoning the 
>clinician to get the hard data), and our existing lab systems are not 
>clever enough to do that. We can only do reflex testing for e.g when 
>potassium < 2.8 add magnesium and so forth.
>
>I agree with Ian that alpha 1 anti-trypsin phenotyping is going to diagnose

>a specific genetic condition, but this is usually the purpose of asking for

>alpha 1 antitrypsin level in the first place and it is a good practice to 
>follow up low levels with phenotyping.
>
>All what I am saying here, is adding tests is a normal laboratory practice 
>in the UK, performed for the good of patients. Laboratory practitioners 
>will have their individual experience with what test to add and when, 
>influenced by the very many cases they discovered over the years. This is 
>the clever bit of their jobs and it is insulting to label it as an assault.
>
>Best wishes
>
>Mohammad
>
>Elizabeth Mac Namara <[log in to unmask]> wrote:
>I have never said that certain tests might not be useful all I have ever 
>said is they should be first discussed with the doctor who ordered the 
>original tests. No one has yet given me any idea as to why such a 
>suggesstion is wrong. What can be lost by talking to the person 
>respponsible for the patient. We are not alone in the laboratory and 
>whether we like it or not the ordering physician, not us is the person who 
>has the right to decide about what should be done in his name on his 
>patient. Not us.
>
>Many of the tests you suggest are of course realistic but if you feel that 
>way why not make it automatic. A computer will always do it better as it 
>will never miss. Then you can let all the docotrs know that under certain 
>circumstances specific tests will be added i.e. a high total bilirubin will

>always result in conj bilirubin being analysed. I do this myself and so 
>would never discuss it with a doctor, they expect it and never order a 
>conjugated bilirubin.
>
>But have you ever done a study on the cost benefit analysis of what you 
>suggest below? What percentage of times to you conform with your 
>suggestions. If it is not you reviewing the tests is it always done?
>
>An anecdotal finding of a disease, once upon a time, is not a guideline to 
>be followed. Yet that is what is being suggested. I know many doctors when 
>in the ED missed acute pancreatitis now do amylase on almost all acute ill 
>patients. They  always cite one patient they missed or a colleague missed 
>once upon a time. But it does not make their practice either a good idea 
>for either the doctor or the patient. Much has been written on the harm 
>unnecessary tests do patients. Look at some of the work by Roizen. I have 
>not seen it lately but it is lovely and very relevent to the present 
>discussion.
>
>Elizabeth Mac Namara

_________________________________________________________________
MSN Search, le moteur de recherche qui pense comme vous !  
http://search.msn.fr

------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.

ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/

Top of Message | Previous Page | Permalink

JiscMail Tools


RSS Feeds and Sharing


Advanced Options


Archives

May 2024
April 2024
March 2024
February 2024
January 2024
December 2023
November 2023
October 2023
September 2023
August 2023
July 2023
June 2023
May 2023
April 2023
March 2023
February 2023
January 2023
December 2022
November 2022
October 2022
September 2022
August 2022
July 2022
June 2022
May 2022
April 2022
March 2022
February 2022
January 2022
December 2021
November 2021
October 2021
September 2021
August 2021
July 2021
June 2021
May 2021
April 2021
March 2021
February 2021
January 2021
December 2020
November 2020
October 2020
September 2020
August 2020
July 2020
June 2020
May 2020
April 2020
March 2020
February 2020
January 2020
December 2019
November 2019
October 2019
September 2019
August 2019
July 2019
June 2019
May 2019
April 2019
March 2019
February 2019
January 2019
December 2018
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
March 2018
February 2018
January 2018
December 2017
November 2017
October 2017
September 2017
August 2017
July 2017
June 2017
May 2017
April 2017
March 2017
February 2017
January 2017
December 2016
November 2016
October 2016
September 2016
August 2016
July 2016
June 2016
May 2016
April 2016
March 2016
February 2016
January 2016
December 2015
November 2015
October 2015
September 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
2006
2005
2004
2003
2002
2001
2000
1999
1998


JiscMail is a Jisc service.

View our service policies at https://www.jiscmail.ac.uk/policyandsecurity/ and Jisc's privacy policy at https://www.jisc.ac.uk/website/privacy-notice

For help and support help@jisc.ac.uk

Secured by F-Secure Anti-Virus CataList Email List Search Powered by the LISTSERV Email List Manager